NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

eFFECTOR Therapeutics Inc (NASDAQ: EFTRW)

 
EFTRW Technical Analysis
5
As on 1st Jul 2022 EFTRW Share Price closed @ 0.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.70 & Strong Sell for SHORT-TERM with Stoploss of 1.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EFTRW Share Price

Open 0.23 Change Price %
High 0.25 1 Day 0.00 0.00
Low 0.20 1 Week -0.03 -10.71
Close 0.25 1 Month -0.06 -19.35
Volume 42 1 Year -0.35 -58.33
52 Week High 2.25 | 52 Week Low 0.12
 
NASDAQ USA Most Active Stocks
ENDP 0.57 21.28%
ALNA 0.21 10.53%
XELA 0.11 0.00%
AMD 73.67 -3.66%
CLVS 2.85 58.33%
AKBA 0.39 11.43%
AMZN 109.56 3.15%
AAPL 138.93 1.62%
NVDA 145.23 -4.20%
AGRX 0.64 -45.30%
 
NASDAQ USA Top Gainers Stocks
REDU 3.41 1075.86%
NDRAW 0.03 200.00%
RCRTW 0.29 141.67%
RMGCW 0.18 125.00%
LCAAW 0.20 100.00%
ENJYW 0.02 100.00%
PTIXW 0.15 87.50%
FRSGW 0.18 80.00%
SPTKW 0.07 75.00%
OMER 4.64 68.73%
 
NASDAQ USA Top Losers Stocks
GGGVR 0.00 -100.00%
PTRAW 0.23 -89.59%
DTOCW 0.07 -74.07%
ITQRW 0.03 -62.50%
MPACW 0.04 -60.00%
NLITW 0.11 -52.17%
NAACW 0.06 -50.00%
MBTCR 0.02 -50.00%
BTAQW 0.01 -50.00%
ALACW 0.01 -50.00%
 
 
EFTRW
Daily Charts
EFTRW
Intraday Charts
Whats New @
Bazaartrend
EFTRW
Free Analysis
 
EFTRW Important Levels Intraday
RESISTANCE0.35
RESISTANCE0.32
RESISTANCE0.30
RESISTANCE0.28
SUPPORT0.22
SUPPORT0.20
SUPPORT0.18
SUPPORT0.15
 
EFTRW Target for Month July
4th UP TARGET3.43
3rd UP TARGET2.41
2nd UP TARGET1.78
1st UP TARGET1.15
1st DOWN TARGET-0.65
2nd DOWN TARGET-1.28
3rd DOWN TARGET-1.91
4th DOWN TARGET-2.93
 
EFTRW Weekly Target
4th UP TARGET4.24
3rd UP TARGET2.96
2nd UP TARGET2.17
1st UP TARGET1.38
1st DOWN TARGET-0.88
2nd DOWN TARGET-1.67
3rd DOWN TARGET-2.46
4th DOWN TARGET-3.74
 
EFTRW Target for Year 2022
4th UP TARGET5.01
3rd UP TARGET3.48
2nd UP TARGET2.54
1st UP TARGET1.6
1st DOWN TARGET-1.1
2nd DOWN TARGET-2.04
3rd DOWN TARGET-2.98
4th DOWN TARGET-4.51
 
 
EFTRW Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EFTRW Address
EFTRW
 
EFTRW Latest News
 
Your Comments and Response on eFFECTOR Therapeutics Inc
 
EFTRW Business Profile
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California. Address:
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service